arrow
A

Annalisa Ruggeri

ospedale san raffaele s.r.l.
H指数:64
被引数:1.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Syndrome-oriented CNS infectious complications after hematopoietic stem-cell transplantation and CAR T-cell therapy, part 1—viral encephalitis, meningitis, and myelitis: recommendations from the Practice Harmonization & Guidelines Committee of the EBMT

造血干细胞移植和CAR T细胞治疗后中枢神经系统感染并发症的综合征导向性研究,第一部分——病毒性脑炎、脑膜炎和脊髓炎:来自EBMT实践协调与指南委员会的建议

2026-11-050
OA
The role of palliative and supportive care in haematopoietic cell transplantation and cellular therapy. Recommendations from the EBMT practice harmonisation and guidelines committee

姑息治疗和支持性护理在造血细胞移植和细胞治疗中的作用。EBMT实践协调与指南委员会的建议

2026-10-260
OAAI
Publisher Correction: defining global priorities in hematopoietic transplantation and cellular therapy: a statement paper from the EBMT global committee

出版商更正:定义造血移植和细胞治疗领域的全球优先事项:EBMT全球委员会的一份声明文件

2026-10-120
OAAI
Defining global priorities in hematopoietic transplantation and cellular therapy: a statement paper from EBMT Global ComMittee

定义全球造血移植和细胞治疗的优先事项:EBMT全球委员会声明文件

2026-08-110
OAAI
Conditioning regimen for hematopoietic cell transplant in transfusion dependent thalassemia: Recommendations from the EBMT practice harmonisation and guidelines committee

输血依赖型地中海贫血造血细胞移植的预处理方案:EBMT实践协调与指南委员会的建议

2026-07-220
PRE
A holistic prognostic model for leukemia-free survival after allogeneic transplantation in acute leukemia

异基因移植后急性白血病患者无白血病生存的综合性预后模型

2026-07-020
OA
Impact of fludarabine dosage on outcomes in large B-cell lymphoma patients treated with CAR T-cell therapy: a retrospective study of the CTIWP of the EBMT

氟达拉滨剂量对接受CAR T细胞治疗的大B细胞淋巴瘤患者预后的影响:EBMT CTIWP的一项回顾性研究

2026-06-060
PRE
Defining lines of therapy in haematological malignancies: a proposed systematic and comprehensive framework from the EBMT Practice Harmonisation and Guidelines Committee

定义血液学恶性肿瘤的治疗线:EBMT实践协调和指南委员会提出的系统性和综合性框架

2026-06-030
OAAI
Access to CAR-T cell therapy in Central and Eastern Europe: persistent barriers and inequalities as of October/November 2025

中东欧地区CAR-T细胞疗法的可及性:截至2025年10/11月的持续障碍与不平等

2026-06-020
PRE
HLA matching in contemporary haematopoietic cell transplantation: Recommendations from the EBMT Practice Harmonisation and Guidelines Committee

当代造血细胞移植中的HLA配型:EBMT实践协调与指南委员会的建议

2026-06-020
OAAI
The 2024 EBMT activity report: crossing one million HCTs and 20,000 CAR-T. A landmark in cellular therapy

2024年EBMT活动报告:完成一百万例HCT和2万例CAR-T。细胞疗法的重要里程碑

2026-05-270
OAAI
Central nervous system complications after allogeneic haematopoietic cell transplantation: best practice recommendations from the EBMT practice harmonisation and guidelines committee on epidemiology, outcome and neuroimaging

异基因造血细胞移植后的中枢神经系统并发症:EBMT实践协调和指南委员会关于流行病学、结局和神经影像学的最佳实践建议

2026-05-130
PRE
Symptom-guided approach to central nervous system complications in allogeneic hematopoietic cell transplant recipients: Best practice recommendations from the EBMT Practice Harmonisation and Guidelines committee

症状指导方法在异基因造血细胞移植受者中枢神经系统并发症中的应用:EBMT实践协调和指南委员会的最佳实践建议

2026-05-070
PRE
Subsequent neoplasms after umbilical cord blood transplantation in the Japanese and European populations
2026-01-250
PRE
Syndrome-oriented CNS infectious complications after haematopoietic stem-cell transplantation and CAR T-cell therapy, part 2—focal brain infections and meningitis of bacterial, fungal, and parasitic origin: recommendations from the EBMT Practice and Harmonization Committee

造血干细胞移植和CAR T细胞治疗后以综合征为导向的中枢神经系统感染并发症,第2部分——细菌性、真菌性和寄生虫性局灶性脑感染和脑膜炎:EBMT实践与协调委员会的建议

2026-01-010
OA